Pharmafile Logo
  • - PMLiVE
  • - PMLiVE
  • Diversity, Equity and Inclusion
  • Communiqué 53 Cover Image

Rodin Therapeutics

Biogen Idec building

Biogen and City Therapeutics to develop RNAi therapies in deal worth over $1bn

The partners will focus on a target that mediates key central nervous system diseases

- PMLiVE

Eli Lilly and Sangamo Therapeutics enter CNS disease partnership worth over $1.4bn

The deal gives Lilly access to Sangamo’s neurotropic adeno-associated virus capsid

Lucid Group acquires US-based strategic brand consultants DiD

Lucid Group has acquired the US-based strategic brand consultants, DiD. This union will strengthen Lucid Group’s existing presence in the US and its ability to provide a compelling strategic, creative...

Lucid Group Communications Limited

- PMLiVE

Integrating competitive intelligence into business development, licensing and M&A strategy

The advantages of partnering with a competitive intelligence or knowledge management team

- PMLiVE

Alkermes’ new antipsychotic clears FDA advisory committee hurdle

Target action date for FDA decision is due on 15 November

- PMLiVE

Pharma funding and M&A in 2020

Why pharma M&A has continually bucked the trend

- PMLiVE

Mergers and acquisitions: agents for change

Getting the best from your agency in a disruptive time

Bedrock Healthcare Communications

- PMLiVE

Troubled Alkermes eyes November OK for new antipsychotic

Review begins for potential schizophrenia and bipolar I disorder drug

- PMLiVE

Lilly expands dermatology portfolio with $1.1bn Dermira deal

Deal includes FDA fast-tracked eczema drug

Roche Basel Switzerland

Roche to close $4.3bn Spark deal after FTC clearance

Comes on the heels of CMA green light

- PMLiVE

UK’s CMA clears Roche’s $4.3bn takeover of Spark

Roche first announced deal in February

- PMLiVE

Novartis acquires The Medicines Company for $9.7bn following takeover rumours

MedCo's cholesterol lowering inclisiran main attraction in planned acquisition

Subscribe to our email news alerts

Latest content

Latest intelligence

Quick links